About: Quality vaccines for all people Report on the 16th annual general meeting of the Developing Countries Vaccine Manufacturers' Network, 05

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Quality vaccines for all people Report on the 16th annual general meeting of the Developing Countries Vaccine Manufacturers' Network, 05–07th October 2015, Bangkok, Thailand Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Quality vaccines for all people Report on the 16th annual general meeting of the Developing Countries Vaccine Manufacturers' Network, 05–07th October 2015, Bangkok, Thailand
source	Elsevier; Medline; PMC
abstract	Abstract The Developing Countries Vaccine Manufacturers Network (DCVMN) assembled high-profile leaders from global health organisations and vaccine manufactures for its 16th Annual General Meeting to work towards a common goal: providing quality vaccines for all people. Vaccines contribute to a healthy community and robust health system; the Ebola outbreak has raised awareness of the threat and damage one single infectious disease can make, and it is clear that the world was not prepared. However, more research to better understand emerging infectious agents might lead to suitable vaccines which help prevent future outbreaks. DCVMN members presented their progress in developing novel vaccines against Dengue, HPV, Chikungunya, Cholera, cell-based influenza and other vaccines, demonstrating the commitment towards eliminating and eradicating preventable diseases worldwide through global collaboration and technology transfer. The successful introduction of novel Sabin-IPV and Oral Cholera vaccine in China and Korea respectively in 2015 was highlighted. In order to achieve global immunisation, local authorities and community leaders play an important role in the decision-making in vaccine introduction and uptake, based on the ability of vaccines to protect vaccinated people and protect non-vaccinated in the community through herd immunity. Reducing the risk of vaccine shortages can also be achieved by increasing regulatory convergence at regional and international levels. Combatting preventable diseases remains challenging, and collective efforts for improving multi-centre clinical trials, creating regional vaccine security strategies, fostering developing vaccine markets and procurement, and building trust in vaccines were discussed.
has issue date	2016-06-30(xsd:dateTime)
bibo:doi	10.1016/j.vaccine.2016.02.067
bibo:pmid	26947496
has license	els-covid
sha1sum (hex)	4bef591a0af76de32c50959f47cd4d9261a09015
schema:url	https://doi.org/10.1016/j.vaccine.2016.02.067
resource representing a document's title	Quality vaccines for all people Report on the 16th annual general meeting of the Developing Countries Vaccine Manufacturers' Network, 05–07th October 2015, Bangkok, Thailand
has PubMed Central identifier	PMC7127051
has PubMed identifier	26947496
schema:publication	Vaccine
resource representing a document's body	covid:4bef591a0af76de32c50959f47cd4d9261a09015#body_text
is schema:about of	named entity 'REPORT' named entity 'DEVELOPING COUNTRIES' named entity 'VACCINES' named entity 'MEETING' named entity 'VACCINE' named entity 'PEOPLE' named entity 'QUALITY' named entity 'GENERAL' named entity 'NETWORK' named entity 'CONFERENCE REPORT' named entity 'ANNUAL' named entity 'Developing Countries' named entity 'vaccine' named entity 'vaccine' named entity 'pertussis' named entity 'Africa' named entity 'A vaccine' named entity 'DTP' named entity 'Immunisation' named entity 'Chikungunya vaccine' named entity 'polio' named entity 'intravesical' named entity 'rubella' named entity 'vaccine' named entity 'measles vaccination' named entity 'cholera' named entity 'vaccine' named entity 'ASEAN' named entity 'Brazil' named entity 'Clinton Health Access Initiative' named entity 'global issue' named entity 'pertussis toxin' named entity 'Serum Institute of India' named entity 'universal health insurance' named entity 'Pharmacovigilance' named entity 'immunisation' named entity 'recombinant technology' named entity 'Vaccine' named entity 'SARS' named entity 'global public health' named entity 'Gavi' named entity 'recombinant' named entity 'Saudi Arabia' named entity 'infectious diseases' named entity 'vaccine' named entity 'vaccine' named entity 'MMR' named entity 'Chinese Academy of Medical Sciences' named entity 'WHO' named entity 'CEO' named entity 'BCG vaccine' named entity 'clinical trials' named entity 'PAHO' named entity 'Bangkok' named entity 'Gavi' named entity 'Vaccine' named entity 'DTP' named entity 'immunisation' named entity 'eradicate polio' named entity 'UNICEF' named entity 'emerging infectious diseases' named entity 'WHO' named entity 'NIH' named entity 'Bill & Melinda Gates Foundation' named entity 'vaccine' named entity 'Clinical Trials' named entity 'phase 3 clinical trials' named entity 'Biotech' named entity 'health professionals' named entity 'WHO' named entity 'serotypes' named entity 'polio eradication' named entity 'Brazil' named entity 'DTaP vaccine' named entity 'pneumococcal vaccine' named entity 'Vero cells' named entity 'India' named entity 'vaccination' named entity 'Prof.' named entity 'China' named entity 'vaccine manufacturing' named entity 'disease prevention'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software